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The number of consumer products containing nanomaterials over the last eight years has 
increased over two-fold. Silver is one of the most commonly used materials in consumer 
goods nanoparticle fabrication.1 Thus, the uptake and biodistribution of silver 
nanoparticles (AgNPs) within mammalian cells can provide insight into their possible 
toxicological effects. In this study, starch-capped AgNPs of an average diameter of 9 ± 5 
nm were synthesized via a bottom-up method, and characterized by Raman spectroscopy, 
transmission electron microscopy (TEM), inductively couple plasma optical emission 
spectroscopy (ICP-OES), and absorption spectroscopy. Vero 76 cells were incubated with 
0.0, 0.1, 1.0, and 3.0 mg L-1 starch-capped AgNPs for 2, 4, 12, and 24 hr in a water 
vehicle control for imaging with CytoViva darkfield microscopy and hyperspectral 
analysis. It was observed that the morphology of the cells was negatively impacted at all 
exposure concentrations in a dose-dependent manner. The cells appear clustered, had 
fewer dendrites forming, and cell debris is visible on the microscope slide.  Vero 76 cells 
were exposed to all concentrations of AgNPs for 4 hr at 0.0, 0.1, 1.0, and 1.5 mg L-1 for 
mitochondrial isolation and total Ag uptake was estimated by ICP-OES. It was 
determined that at exposure concentrations of 1.0 and 1.5 mg L-1, AgNPs remained in the 
incubated Dulbecco’s Modified Eagle Medium (DMEM), 86% and 77%, respectively. A 
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bicinchoninic acid (BCA) protein assay was also performed under similar conditions in 
order to examine cell viability. Cellular toxicity was found to be concentration 
dependent; the smallest cell viability value (7%) was observed at the highest 
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1.1. Silver Nanoparticles (AgNPs) 
1.1.1. Background of Silver Nanoparticles 
According to the U.S. Environmental Protection Agency (EPA), a nanoparticle is 
characterized as a particle with at least two dimensions within the range of 1 to 100 nm.2 
The use of nanomaterials in everyday life seems unreal, yet they are found in consumer 
goods from health and fitness to goods for children, as well as in the medical field 
(Figure 1). This is largely due to nanoparticles having unique physicochemical 
characteristics (PCCs) when compared to the bulk material. These PCCs are: 
composition, size, size distribution, shape, surface area, surface chemistry, surface 
charge, purity, aggregation state, solubility, stability, and surface reactivity.3 All of these 
characteristics can be tailored during nanofabrication by means of the choice of reducing 
agent and capping agent. According to the Consumer Product Inventory issued by The 
Project on Emerging Nanotechnologies, the nanotechnology sector has vastly grown to 
over a trillion dollars.4,5 With the growth of this industry, the possible impact of 
nanoparticles on humans and the environment became an important topic of research and 




 Figure 1. Total number of consumer goods containing nanomaterials by material (N = 
383, N = 150, N = 123, N = 75, N = 73, N = 55, N = 43, N = 44, N = 46, N = 26, N = 26, 
N = 25, N = 21, N = 19, N = 17, N = 13, N = 11, N = 10, N = 14, and N = 10, 
respectively) and category. (Charts reconstructed by Miriam Crane from data in The 
Nanodatabase)1  
 
The most commonly used metal in the nanoparticle fabrication is silver. This is due to its 
antimicrobial and antibacterial properties (Figure 1).6,7 Studies on Gram-positive and 
Gram-negative bacteria show that AgNPs have inhibitory and bactericidal effects.8,9 
Numerous in vivo and in vitro studies have found that AgNPs have cytotoxic and 
genotoxic effects in both animal and human cell lines.10,11,12,13,14 While there is no EPA 
standard limiting the amount of AgNPs within consumer goods, there is a limit set for 
ionic silver in drinking water of 0.10 mg L-1 (i.e., the Secondary Maximum Contaminant 
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Level).15 Thus, the mechanism by which the AgNPs are causing cellular toxicity is of 
great interest. 
1.1.2. Common Fabrication Techniques of Nanoparticles 
There are numerous fabrication methods for AgNPs, but two main techniques are top-
down and bottom-up approaches (Figure 2). 
 
Figure 2. Top-down and bottom-up approaches for nanoparticle fabrication. 
The top-down technique is the process of taking a bulk material and breaking it down by 
means of finer and finer tools to a smaller scale until the nanoscale level is reached. This 
can be done by means of mechanicanosynthetic methods, thermal methods, and chemical 
fabrication. Mechanicanosynthetic methods include ball milling by abrasion, compaction 
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and consolidation, which are used to make nanocomposites. The mechanical top-down 
methods are largely employed in industry because they are less expensive to scale-up to 
production volumes. The thermal methods such as laser ablation, arc discharge, solar 
flux, and plasma methods require an excessive high energy input; therefore, the potential 
for scale-up and quality control are restricted. Top-down chemical fabrication methods 
are widely utilized in industry because of the scale-up is easier to implement. Other 
chemical fabrication methods commonly exploited in industry include anodizing, 
lithography, and nanoimprint lithography. 
The bottom-up technique starts at the atomic or molecular level and is driven by a natural 
physical property or an applied external force to give rise to larger, more organized 
systems. Chemical vapor deposition, atomic layer deposition, and molecular beam 
epitaxy are used in industry. Electrodeposition and electroless deposition are simple ways 
to manufacture various forms of nanomaterials. Numerous liquid phase methods are low 
cost and can be scaled-up.16 Thus, the liquid phase method  is selected for the fabrication 
of AgNPs in this thesis. 
1.1.3. Background on Starch-Capped AgNPs 
As mentioned above, a liquid phase method was selected to fabricate starch-capped 
AgNPs. The cytotoxicity and genotoxicity of these AgNPs have been studied in 
zebrafish, human cells, and bacteria models, just to name a few.10, 17 This is a green 
method for nanomaterials fabrication as it uses nontoxic reducing/capping agent(s), 
environmentally benign solvents, and/or renewable materials. The reducing/capping 
agent in this thesis work is a soluble polysaccharide, namely potato starch (Figure 3). 
This reducing/capping agent is nontoxic, environmentally friendly, and widely available. 
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In a previous study, starch alone (2.8% w/v) was found to have no cytotoxic effect in 
normal human lung fibroblasts and human glioblastoma cells, thus confirming its 
biocompatibility.11 Amylose is a soluble starch, which in aqueous solutions forms a left-
handed helical conformation chain with linkages α (1→4) between D-glucose 
subunits.17,18   
 
Figure 3. Depiction of the structure of amylose chain formed by the α (1-4) linkages 
between D-glucose subunits (Structure made via ChemDoodle). 
Due to its conformation in water, starch behaves as a linear polymer by forming films and 
complexes with ligands. The theorized mechanism of reduction of silver nitrate is by its 
reaction to the terminal aldehyde of the starch and stabilization of the nanoparticle by the 
starch itself.19 
1.2. Mammalian Cell Biology Background 
Mammalian cells are eukaryotic cells; this means that the cell contains organelles that 
carry out specialized functions. Each organelle is bound by a membrane, which controls 
the flow of molecules and ions into/out of the cell and thereby maintains its specialized 
α 1 4 
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environment. The structure of a mammalian cell and the various types of organelles are 
displayed in Figure 4. 
 
Figure 4. Depiction of a mammalian cell with its various organelle labeled (purchased by 
Miriam Crane on stockphotos.com; Order # 73684). 
 
Briefly, the main organelles of mammalian cells are the endoplasmic reticulum (ER), 
Golgi body, ribosomes, nucleus, centriole, mitochondrion, plasma membrane, and 
cytoskeleton. The ER, Golgi body and ribosomes are composed of polypeptide chains 
and lipids. The cytoskeleton contributes to cell shape and movement, where the plasma 
membrane selectively controls what moves in and out of the cell. The centrioles are 
associated with cell division. The nucleus houses, protects, and controls access to the 
deoxyribonucleic acid (DNA). Mitochondria are responsible for key stages of cellular 
respiration, including the citric acid cycle and oxidative phosphorylation. It is the main 
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site for adenosine triphosphate (ATP) production, which provides the energy source for 
the cell. Understanding the interactions between AgNPs and mitochondria will give 
insight into key toxic effects. 
Mammalian cells undergo a process called endocytosis to ingest nutrients, fluids, and 
other molecules needed for survival (Figure 5).20  
  
Figure 5. Macromolecules being internalized by the process of endocytosis. (Figure 
courtesy of SERVIER Medical Art, https://smart.servier.com/) 
 
Macromolecules are internalized by the plasma membrane surrounding the nutrients, 
which buds off inside the cell forming what is called a vesicle. Once the macromolecule 
is inside the cell, catabolism, i.e., the degradation of complex molecules into simpler ones 
by means of enzymatic breakdown, takes place in lysosomes. Digestion of the 
macromolecule into its subunits allows for the cell to utilize them for glycolysis (derived 
from the Greek words glykys, “sweet”, and lysis, “splitting”), which takes place in the 
cytosol. The next two stages of cellular respiration, the citric acid cycle and oxidative 
breakdown, happen solely in the mitochondria.21  
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1.2.1. Structure and Function of Mitochondria  
As mentioned previously, mitochondria of a cell are the main site for energy production 
in the form of ATP, which is produced through cellular respiration. Figure 6 displays the 
structural components of a mitochondrion.   
 
Figure 6. Representation of a mitochondrion and its specific parts (purchased by Miriam 
Crane on stockphoto.com; Order 106975). 
 
The mitochondrion has four separate compartments within its structure: outer membrane, 
inner membrane, matrix, and intermembrane space. A unique set of proteins can be found 
in each compartment that enable it to perform its function. Both the outer and inner 
membrane are composed of phospholipid bilayers with their unique set of proteins 
imbedded into them. The outer membrane contains channel-forming proteins called 
porin, which form wide aqueous channels through the lipid bilayer and make the 
membrane permeable to molecules less than 5,000 Daltons. The inner membrane is 
highly folded into cristae, which contain proteins to carry out oxidation reactions during 












molecules within the matrix of the mitochondrion. The inner and outer membranes form 
an intermembrane space between the two of them; this contains several enzymes that use 
the ATP passing out of the matrix to phosphorylate other nucleotides. The matrix is 
comprised of a highly concentrated mixture of enzymes required for oxidative reactions 
as well as other metabolic pathways. All these compartments play a key role in the citric 
acid cycle and the electron transport chain (i.e., oxidative phosphorylation). Figure 7 
depicts two key parts of cellular respiration: the electron transport chain and the citric 
acid cycle.21 
 
Figure 7. Depiction of the citric acid cycle and the membrane-based mechanism of the 
electron-transport chain of mitochondria. (Figure constructed with images courtesy of 




The first part of cellular respiration, glycolysis, takes place in the cytosol of the cell and 
breaks down simple subunits to pyruvate. Pyruvate is pumped into the mitochondrial 
matrix, where it undergoes decarboxylation by three enzyme complexes (the pyruvate 
dehydrogenase complex) to produce reduced nicotinamide adenine dinucleotide 
phosphate (NADH), carbon dioxide (CO2), and acetyl Coenzyme A (CoA). Acetyl CoA 
then enters the citric acid cycle where it undergoes oxidative breakdown to form NADH 
and flavin adenine dinucleotide (FADH2). Both NAD
+ and FAD are important high-
energy electron carriers, in their reduced form they carrier electrons and hydrogen. 
NADH and FADH2 transfer the electrons to the last step in the oxidation of nutrients: the 
electron transport chain. This is the step in which most chemical energy of a cell is 
produced in the form of ATP. The electron transport chain is a membrane-based 
mechanism, meaning the complexes are embedded within the phospholipid bilayer of the 
inner membrane of the mitochondrion. Ions are transported across the membrane by four 
protein complexes; the electron transfers release energy used to pump protons (H+) from 
omnipresent water within the cell across the membrane generating an electrochemical 
proton gradient.  The H+ flow back into the matrix through a protein complex called ATP 
synthase, which catalyzes the energy required for the synthesis of ATP from adenosine 
diphosphate (ADP) and inorganic phosphate. If the metabolic reactions and processes are 
interrupted, this can cause the cells’ ATP content to drop, meaning possible apoptosis 
(cell death) could occur.21 
1.3. Background on Vero 76 Cell Line 
The biological matrix chosen for this project was Vero 76 cells, which were derived from 
a kidney of a normal adult African Green monkey (Cercopithecus aethiops) in the 1960s. 
11 
 
This cell line is well established in continuous mammalian cell research. The 
characteristics of this cell line are that they are anchorage-dependent, dendritic, and must 
be cultured before 100 % confluency (amount of cell culture dish covered by cells) is 
reached or cell death will occur.22 Figure 7 displays an image of the cells at 
approximately 70 % confluency, note the dendric shape. These dendrites allow for the 
cells to communicate. 
 
Figure 8. Optical image of a monolayer of Vero 76 cells grown to ~ 70 % confluency. 
 
1.4. Knowledge Gaps 
The biomedical applications of AgNPs are limited by the lack of well-established 
























1.5. Main Goal and Specific Aims 
Main Goal: 
Quantify total silver absorbed by whole Vero 76 cells and their mitochondria via ICP-
OES and follow silver nanoparticle distribution by hyperspectral CytoViva imaging. It is 
thought that as concentration exposure of AgNPs and time of incubation are increased, 
the cytotoxic effects will increase.10,17 
Specific Aim 1: 
Synthesize, purify, and characterize starch-capped AgNPs via centrifugation and 
tangential flow filtration (TFF), ultraviolet and visible absorption spectroscopy (UV-Vis), 
transmission electron microscopy (TEM), CytoViva hyperspectral microscopy, Raman 
spectroscopy, and inductively coupled plasma-optical emission spectroscopy (ICP-OES).  
Specific Aim 2: 
Isolate and determine total cellular protein content of whole Vero 76 cells and their 
mitochondria before and after exposure to colloidal AgNPs via a mitochondrial isolation 
assay. 
Specific Aim 3: 
Quantify the total silver content within these biological matrices by ICP-OES and 






2.1. Chemicals and Materials 
Silver nitrate (> 99%, solid, AgNO3) was manufactured by Acros Organics. A trace metal 
grade ICP-OES silver standard (1.00 x 103 mg L-1) was purchased from CentraPrep. Trace 
metal grade nitric acid (70%, TM HNO3) and soluble starch (powder, C12H22O11) were 
acquired from Fisher Scientific. All chemicals and reagents were used as received, 
without any further purification. High quality water (> 18 MΩ cm, HQ H2O) was utilized 
as a solvent. 
Vero 76 cells (ATCC® CRL #1587TM) were procured from American Type Culture 
Collection. Dulbecco's Modified Eagle's Medium/High Glucose (DMEM), penicillin-
streptomycin glutamine (100x, PS), and trypsin (0.05%) with EDTA (0.53 M) were 
obtained from HyClone. Fetal bovine serum (FBS) was purchased from Corning. 
Phosphate buffered saline (1x, PBS), hydrogen peroxide (30%), and formaldehyde (37%) 
were acquired from Fisher Bioreagents. MitoTracker red CMXRos (MT red) was attained 
from Invitrogen. Mitochondrial isolation kit and bicinchoninic acid (BCA) protein assay 




2.2. AgNP Synthesis and Purification 
2.2.1. Synthesis and Purification via Centrifugation 
Starch-capped AgNPs were synthesized by a one-pot green synthesis method in an 
autoclave bottle.19 Briefly, 1.0 g of soluble starch was dissolved through heating in 100 
mL of HQ H2O on a hot plate at ~ 90° C for ~ 1 hr. Afterward, 1 mL of AgNO3 solution 
(100 mM) was added all at once and mixed through manual stirring. The resulting 
mixture was immediately autoclaved at 15 psi and 121 °C for 20 min. The resulting 
colloid was light-yellow in color (Figure 9A), which confirmed the formation of AgNPs. 
After cooling to room temperature, the colloid was passed through a 0.2 μm syringe filter 
(Figure 9B). The colloid was then centrifuged at 14,000 rpm (22,789 g) for 1 hr and the 
resulting pellet containing AgNPs was washed twice with HQ H2O through similar 
centrifugation in order to remove excess starch (Figure 9C-9E). AgNPs collected at each 
step of the centrifugation process in the pellet were redispersed through ultrasonication 
(output power of 25-43 Watts) for ~ 20 to 30 s into fresh HQ H2O. The purified colloid 





Figure 9. Image of original colloid (A), 0.2 μm permeate (B), supernatant (C), wash #1 
supernatant (D), wash #2 supernatant (E), and redispersed pellet for TFF process (F).  
2.2.2. Size-Selection, further Purification, and Concentration via Tangential Flow 
Filtration (TFF)  
The TFF process was applied as described in literature.23 In this study, the size selection, 
further purification, and concentration of the centrifuged AgNPs colloid (80 mL) was 
achieved manually through a one-step tangential filtration (Scheme 2.1) with a 70 kD 
modified polyetherethersulfone Midi Kros filter module (115 cm2, > 10 nm pore size, from 
Spectrum Labs, Inc.) and polypropylene syringes for sample injection (Figure 10A). The 
final 70 kD retentate of starch-capped AgNPs maintained its characteristic color (Figure 10B) 
and was used in cell experiments within one week from filtration. 
A  B  C  D  E         F 
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Scheme 2.2-1. Flow diagram for tangential flow filtration of AgNPs. 
 
 
Figure 10. Image of the TFF setup (A) and the final 70 kD retentate of AgNPs for cellular 
experiments (B). 
2.3. AgNPs Characterization 
Ultraviolet and visible (UV-Vis) absorption spectroscopy, inductively coupled plasma 
optical emission spectroscopy (ICP-OES), Raman spectroscopy, Transmission Electron 
Microscopy (TEM), and CytoViva Hyperspectral microscopy were employed for the 
characterization of the concentrated AgNP colloid. 
A 
B 
Original colloid Retentate 
70 kD 
> 10 nm 
 
Permeate 
= AgNPs of various 
sizes 
= Water 









2.3.1. Ultraviolet and Visible (UV-Vis) Absorption Spectroscopy 
A Varian Cary 50 Bio UV-Vis spectrophotometer was utilized to collect the absorption 
spectra of colloidal samples (200-800 nm) in disposable cuvettes (1 cm optical path), at a 
fast scan rate (spectral resolution of 1 nm). Absorption readings in the UV-range, a quartz 
cuvette (1 cm optical path) was utilized. All spectra were baseline corrected with respect 
to water before analysis in Origin 8 software. 
2.3.2. Inductively Coupled Plasma Optical Emission Spectroscopy (ICP-OES) 
In preparation for ICP-OES measurements, an acid digestion was performed on all 
colloidal samples of interest. A 10 μL sample aliquot was added to 5 mL of TM HNO3 at 
room temperature and allowed to cold digest for 10 min. The sample was then heated on 
a hot plate at ~ 275° C to evaporate the acid solvent, until approximately 10 μL of sample 
remained. Once cooled to room temperature, the sample was quantitatively rinsed into a 
10 mL volumetric flask with 286 μL of TM HNO3 to a final 2% HNO3 matrix. An 
external calibration was performed using 10 standards ranging from 0 – 350 μg L-1, 
which were made from an ionic silver standard (1,000 mg L-1) by quantitative dilutions in 
2% HNO3 acid matrix.  
ICP-OES analysis was performed on a Varian 710-ES system under the following 
operating conditions: wavelengths of 328.068 nm and 338.289 nm for silver emission, 
plasma flow of 15.0 min-1, auxiliary flow of 1.50 L min-1, and radio frequency power of 
1.2 kW. Samples were measured in triplicate with a replicate acquisition time of 15 s, an 
internal stabilization time of 40 s, and an uptake delay time of 45 s. 
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2.3.3. Raman Spectroscopy 
Colloidal samples were placed into a 2 mL quartz cuvette (1 cm optical path) to collect 
their Raman spectra on a Horiba LabRam HR800 Raman spectrometer with an excitation 
line of 532 nm from a Nd: YAG green internal laser (15 mW output). Data was collected 
from 100-4000 cm-1, utilizing the confocal Raman BX41 microscope, Olympus 100x and 
50x objectives, a confocal hole of 300 μm, a holographic grating of 600 grooves mm-1, 
and a thermoelectrically cooled Andor CCD camera (1024 x 256 pixels). The acquisition 
times and number of cycles were 3 s and 3, respectively. The spectral resolution in each 
measurement was ~ 1 cm-1. Data was collected on LabSpec v.5 software and analyzed 
using Origin 8 software. 
2.3.4. Transmission Electron Microscopy (TEM) 
A 5 μL colloidal sample was drop casted onto a 300-mesh copper grid equipped with a 
lacey carbon support film and allowed to sit at room temperature for 24 hr in a desiccator 
for subsequent drying. AgNP samples were analyzed on a Philips EM 208S TEM coupled 
to a high resolution Gatan Bioscan camera; all images were captured under a 70-kV 
electron beam. ImageJ and Origin 8 software were employed for particle analysis and 
size distribution plots, respectively. 
2.3.5. CytoViva Hyperspectral Imaging  
A 5 μL sample was placed onto a glass microscope slide, covered with a microscope 
coverslip, and allowed to air dry for 15 to 20 min, then sealed with clear nail polish. 
Images were collected with 10x air, 60x and 100x oil immersion objectives on an 
Olympus BX 53 CytoViva enhanced dark field microscope and the Ocular software. The 
ENVI software was employed for the hyperspectral data collection with exposure time 
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varying from 0.5–1.0 seconds and 696 x 696 pixels. Data was analyzed using Origin 8 
software. 
2.4. Preparation and Analysis of Vero 76 Cells 
2.4.1. Culture cells 
Adherent Vero 76 cells were grown in 100 mm petri dishes, in complete growth media 
made up of 89% DMEM, 10% FBS, and 1% PS. The cells were incubated at 37° C in a 
5% CO2
 environment and were cultured to ~ 75% confluency before splitting or counting.  
2.4.2. Total Cellular Protein Determination 
Colorimetric detection and quantitation of total protein within a sample for the purpose of 
determining percent of viable cells was performed via a bicinchoninic acid (BCA) assay 
kit. A set of 9 external calibration standards ranging from 0 – 2,000 mg L-1 were prepared 
from a bovine serum albumin stock of 2 g L-1 by quantitative dilutions in 1x PBS. Cells 
were harvested by trypsinization with 10 mL of trypsin for 4 min and subsequent 
centrifugation at ~1,243 rpm (630 g) for 10 min. The supernatant was removed, and the 
cell pellet was redispersed into 2 mL of 1x PBS. This was followed by the addition of 2 
mL of NaOH solution (1 mM) for lysing purposes. The standards and cell samples of 
interest (25 µL of each) were then placed in a 96-well plate and 200 µL of a proprietary 
reagent mix (50:1 ratio of Reagent A to Reagent B) was added to each well. After 
incubation at 37 °C for 30 min in the cell incubator, the light absorbance was measured at 
562.0 nm via a Varian Cary 50 microplate reader extension of the Varian Cary 50 Bio 
UV-Vis spectrophotometer. Total cellular protein content was determined before and 
after exposure to AgNPs. 
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2.4.3. Staining with MT-red, Exposure to AgNPs, and Fixing Cells for CytoViva 
Hyperspectral Microscopy 
Vero 76 cells were grown on glass coverslips in 35 mm petri dishes for 12-24 hr prior to 
staining with MT-red. Two milliliters of 150 nM MT-red dye were added and incubated 
at 37° C in a 5% CO2 environment for 30 min. Residual dye was removed by washing 
three times with 1x PBS solution. Cells were then exposed to varying final well 
concentrations (0, 0.1, 1, and 3 mg L-1) of AgNPs and incubated at 37° C in a 5% CO2 
environment for 2, 4, 12, and 24 hr. After exposure to AgNPs, the cells were washed 
three times with DMEM, followed by three washes of 1x PBS to remove any residual 
AgNPs. Cells were then fixed in a 3.7% formaldehyde solution that was pipetted directly 
onto the coverslip and allowed to sit for 20 min in the dark. The cells were then washed 
three times with 1x PBS to remove any residual formaldehyde. A drop of 1x PBS was 
pipetted onto a clean glass microscope slide, the coverslip was placed onto the slide, and 
sealed with clear nail polish. The analysis parameters were the same as stated above 
(Section 2.3.4). Fluorescence emission analysis was also performed using a triple pass 
filter and a Prior Lumen 200 light source. Data was processed using GIMP and Origin 8 
software. 
2.4.4. Preparation of ICP-OES samples  
Vero 76 cells were grown in tissue culture flasks (surface area175 cm2) until ~ 75% 
confluent. Cells were then exposed to various concentrations (0, 0.1, 1, and 1.5 mg L-1) of 
AgNPs and incubated at 37° C in a 5% CO2 environment for 4 hr before harvest. The 
AgNP containing media was first removed by pipet and a sample aliquot was saved for 
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further analysis. The plate was then washed with PBS (1x) to remove any residual 
AgNPs; all washings were saved for analysis.  
Approximately 10 mL of trypsin was added to the T-flask and incubated for 4 min at 37° 
C in a 5% CO2 environment. Trypsin cleaves the proteins that are responsible for 
adhering the Vero 76 cell to the plate. After 4 min, the plate was removed from the 
incubator and 40 mL of fresh media was added to the plate to inhibit the trypsin. The cell 
suspension was pipetted up and washed down the flask three times, then pipetted up and 
down a total of six times, with a final washed down to ensure the cell suspension was 
thoroughly mixed. The cell suspension was centrifuged at ~1,243 rpm (630 g) for 10 min 
to obtain a cell pellet. The supernatant was pipetted off and saved for ICP-OES analysis. 
The pellet was then used for mitochondrial isolation.  
Mitochondrial isolation was performed by means of a mitochondrial isolation kit for 
cultured cells. The pellet was redispersed in 2 mL of DMEM and transferred to a 2 mL 
micro-centrifuge tube. The cell suspension was centrifuged at 3,057 rpm (900 g) for 2 
min to repellet the cells. The supernatant was then removed, and reagent A (800 μL) was 
added. The pellet was vortexed at 1,500 rpm (6 g) for 5 seconds and incubated on ice for 
2 min. Reagent B (10 µL) was added, and vortexed at 3,000 rpm (25 g) for 5 seconds. 
The cell suspension was incubated on ice for 5 min while vortexed at 3,000 rpm (25 g) 
every minute. Reagent C (800 µL) was added to the cell suspension, the tube was 
inverted several times followed by centrifugation at 2,696 rpm (700 g) for 10 min. The 
supernatant was then transferred to a new 2 mL micro-centrifuge tube and centrifuged at 
3,530 rpm (12,000 g) for 15 min. The resulting supernatant was removed by pipetting. 
Reagent C (500 µL) was then added to the pellet and centrifuged at 3,530 rpm (12,000 g) 
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for 5 min. The supernatant was removed leaving the isolated mitochondria pellet. The 
isolated mitochondria were redispersed in 2 mL of 1x PBS, and vortexed until 
homogeneous. Aliquots were collected at each step in the mitochondrial isolation for 
ICP-OES analysis. The ICP-OES samples were prepared via the method described above, 
apart from 2 mL of 30% hydrogen peroxide for bleaching purposes prior to evaporating 





3. Results and Discussion 
3.1. Characterization of AgNPs 
In order to confirm the presence of AgNPs in the original colloid, UV-Vis absorption 
spectroscopy was performed on all supernatants associated with the centrifugation 
process and the TFF products. Absorption spectra of the original colloid, 0.2 μm filtrate, 
supernatant/washes of pellet and the final 70 kD retentate AgNPs are shown in Figure 11. 
  
Figure 11. UV-Vis absorption spectra of original colloid, 0.2 μm permeate, 
supernatant/wash of pellet and diluted 70 kD retentate (1:10) showing the characteristic 
Surface Plasmon Resonance peak (SPR) peak of AgNPs.  
The present of the Surface Plasmon Resonance (SPR) peak at 413 nm confirms the 
formation of colloidal AgNPs. The SPR peak suggests the AgNPs are spherical in shape. 
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The characteristic SPR peak was maintained throughout the centrifugation and TFF 
manipulation processes. A small shift in the SPR peak (411 nm) was seen after the TFF 
process was applied. This is probably an indication of the reduction in the average size of 
AgNPs after filtration as a result of the removal of larger AgNPs or AgNPs-aggregates. 
To confirm excess starch was removed during the centrifugation process, UV-Vis was 
performed on all supernatants associated with the centrifugation process, the 70 kD 
retentate TFF product, and a 1% starch solution for comparison (Figure 12).  
 
Figure 12. UV-Vis absorption spectra of 1% starch solution, original colloid, 0.2 µm 
filtrate, supernatant/washes, and diluted 70 kD retentate (1:20) starch-capped AgNPs 
showing the removal of starch throughout the centrifugation and TFF processes. 
 
The 1 % starch solution had an absorbance greater than 1, but it is seen that starch 
absorbs in the UV range. The spectrum corresponding to the original starch-capped 
AgNPs, after the SPR peak, has an absorption in the UV range characteristic to starch. 
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After the centrifugation process, the profile of the UV-vis spectrum of the 70 kD retentate 
starch-capped AgNPs profile changes in the UV region, and the SPR remains the same, 
this is indicative of excess starch being removed from the colloid. The supernatant of 
wash 1 absorbs in the UV range, consistent with the characteristic spectra of starch, 
confirming excess starch was removed. 
To confirm that the filtered colloid was pure and free of excess reagents, Raman 
spectroscopy was performed on the 70 kD retentate. The Raman spectrum of the final 70 
kD retentate of starch-capped AgNP colloid is shown in Figure 13. 
 
Figure 13. Raman spectrum of 1% starch solution and diluted 70 kD retentate starch-
capped AgNP colloid showing characteristic peaks corresponding to water, thus 
confirming purity. 
 
The observation of peaks characteristic to water confirmed the purity of colloid. The 
smallest peak at ~1651 cm-1 corresponds to the - OH bending mode, the shoulder at 
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~3255 cm-1 is due to the symmetric - OH stretch, and the most intense feature at ~3384 
cm-1 results from the asymmetric - OH stretch.24 The Raman spectrum for the 1% starch 
solution utilized for the reduction and capping of the AgNPs is shown for comparison. It 
should be noted that two peaks below 1000 cm-1 are in both spectra, this might be due to 
the starch. 
In order to determine the concentration of the AgNPs colloid, ICP-OES measurements 
were performed on the original colloid and the aliquot samples collected at every step of 
the centrifugation and TFF processes. The 10-point external calibration curve used for 
ICP-OES analysis is displayed in Figure 14. 
 
Figure 14. A representative ICP-OES 11-point external calibration curve together with 





Table 1 summarizes the ICP-OES results. It can be noted that AgNPs were lost in the 
supernatant during the centrifugation process. Approximately 325 mL of the original 
colloid of AgNPs was centrifuged, which resulted in ~ 80 mL of pellet containing 
AgNPs. The pellet was filtered through a 70 kD TFF filter, and ~ 5 mL of final colloid 
was attained.  
Table 1. Total silver concentration of each colloid/supernatant throughout the 
centrifugation and TFF processes were determined via ICP-OES. 
Sample Ag Concentration (mg L-1) 
Original colloid 104 
0.2 µm filtrate 110 
Supernatant of pellet 108 
Supernatant of wash 1 9 
70 kD permeate 6 
70 kD retentate 156 
  
To confirm the morphology and size-distribution of the starch-capped 70 kD retentate 
AgNPs, TEM was performed (Figure 15). It can be seen the starch-capped AgNPs are 
spherical in shape; as they can be visualized as darker black silver cores embedded in a 
lighter grey starch matrix. This was further confirmed by CytoViva images collected on 
the AgNP samples before (Figure 17A) and after (Figure 17B) purification through 




Figure 15. TEM micrograph of 70 kD retentate starch-capped AgNPs confirming 
morphology and size distribution.  
 
Multiple TEM micrographs were utilized to create a histogram (N = 335) in ImageJ 
software (Figure 16). It was determined that the size distribution ranged from 4 nm to 24 




Figure 16. Histogram of particle size distribution (N = 335 AgNPs) compiled from TEM 
micrographs. 
 
After confirming size and shape via TEM, CytoViva images and hyperspectral data were 
obtained on the 70 kD retentate starch-capped AgNPs (Figure 17). Spectra of the 
different colored AgNPs were collected (N = 30). This gives a spectral fingerprint and 
allows for the determination if the AgNPs are entering the cell and its organelles. 
Hyperspectral data were collected before and after the centrifugation/TFF processes to 
compare the spectral fingerprints. 





Figure 17. Characteristic CytoViva images of A) original starch-capped AgNP colloid, C) 
averaged hyperspectral of original starch-capped AgNP colloid, B) final 70 kD retentate 
starch-capped AgNPs and D) averaged hyperspectral of 70 kD starch-capped AgNPs 
used for cellular experiments (N = 30).  
The full width half maximum values for the different colored AgNPs were calculated 
(Table 2).  
Table 2. Surface plasmon resonance maxima and full width half maximum values of 





Blue 497 187 
Green 549 184 










3.2. Determination of Total Cellular Protein Content 
The total cellular protein content determines the percentage of viable cells before and 
after exposure to AgNPs. A calibration curve was constructed from absorbance readings 
at 562 nm versus known concentrations of bovine albumin (Figure 18). This assay is 
employing the biuret reaction, which is the reduction of Cu+2 to Cu+1 by a protein in an 
alkaline medium and demonstrates a strong absorption at 562 nm.   
 
Figure 18. A representative absorbance 9-point external calibration curve together with 
the interpolation equation and R2 value used to determine the total cellular protein 
content in each sample. 
Utilizing the calibration curve made by serial dilutions from a 2 mg mL-1 bovine albumin 
standard, the total cellular protein content at each exposure concentration was determined 
by interpolation (Table 2).  
32 
 
Table 3. BCA assay data of total cellular protein content for each 4 hr exposure to AgNPs 
and vehicle control. 
AgNP Exposure Concentration 
(mg L-1) 
Total Cellular Proteins 
(µg mL-1) 
Percentage of Viable Cells 
(%) 
Vehicle Control 2600 ± 600 51 
0.0 5100 ± 300 100 
0.1 1100 ± 100* 21 
1.0 1600 ± 200* 32 
1.5 2300 ± 300* 46 
3.0 400 ± 50 7 
* No significant mean difference from each other (P = 0.2). 
The total cellular protein content at 0.0 mg L-1 of AgNPs was 5100 µg mL-1, which will 
be referred to as 100% viable cells. The vehicle control alone (2.2 mL of HQ H2O in 47.8 
mL of DMEM) reduced the number of viable cells by 49 % meaning that the amount of 
water added to the cells induced lysing. Despite the vehicle control having adverse effects 
on the cell population, a trend can still be seen with the addition of AgNPs. Exposure to 
0.1, 1, 1.5, and 3 mg L-1 of AgNPs caused 79%, 68%, 54%, and 93% of viable cells to 
die, respectively. If the percent of the dead cells associated with the vehicle control (2.2 
mL of HQ H2O for each exposure) is subtracted from these percentages corresponding to 
AgNP exposures, 30%, 19%, 5%, and 43% of cell death was caused by 0.1, 1.0, 1.5, and 
3.0 mg L-1. More cell death occurred at lower concentrations, except at the highest 
concentration (3 mg L-1). The effect of the vehicle control along with the AgNPs may be 
responsible for the higher cell deaths at exposure concentrations. At an exposure level of 
3 mg L-1 of AgNPs, there was only 7% of viable cells. Thus, the mitochondrial isolation 
could not be performed at this exposure concentration. It would be expected that the 
percentage cell viability would decrease with increasing exposure concentrations. A one-
way ANOVA was run to determine if there was any significant difference between the 
concentration exposures of 0.1, 1.0, and 1.5 mg L-1. Based on a p-vale of 0.20, there is 
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not enough evidence to suggest there is a significant mean difference between any of the 
three concentrations. The trend seen in the data was not what was hypothesized, this 
might be because only three experiments were performed at each AgNP exposure 
concentration. Another reason for the trend in the data might be attributed to cellular 
growth. Even though the cell lines were all cultured under the same conditions, some may 
have differed in growth rate, leading to a different number of cells in each exposure plate. 
3.3.  Imaging of Exposed Vero 76 Cells via CytoViva Hyperspectral Microscopy  
Exposed Vero 76 cells were imaged via CytoViva Hyperspectral Microscopy in order to 
observe the biodistribution of AgNPs within the cells. Cellular morphological changes 
were observed as a result of the AgNP exposure. All CytoViva samples were stained with 





Figure 19 displays the CytoViva optical images of cells superimposed on the 
corresponding fluoresence images after 2 hr exposure to various concentrations of 
AgNPs. In Figure 19a, the control image (0 mg L-1) displays a healthy cell. It should be 
noted that these control cells exhibited normal the dendridic features and an even 
distribution of mitochondria throughout the cytoplasm. After exposure to 0.1 mg L-1 for 2 
hr (Figure 19b), the mitochondria were no longer dispersed evenly within the cytoplasm. 
Figure 19. CytoViva optical images overlaid with fluorescence images of exposed Vero 
76 cells after exposure to a) 0, b) 0.1, c) 1.0, and d) 3.0 mg L-1 of starch-capped AgNPs 
for 2 hr. All cells were stained with 150 nM of Mito-tracker red dye prior to AgNP 





As the exposure concentration increased, this trend increased as well. The morphology of 
the cell drastically changed with the increase of exposure concentration. In Figure 19c 
and Figure 19d, the cell shape is no longer smooth in appearance and looks compromised. 
These obsevations suggest that these cells might be in different stages of cell death. 
Figure 20 is comprised of the corresponding hyperspectral data for the above mentioned 
AgNP exposure concentrations at 2 hr. Data from all AgNPs seen on the cell were 
collected and then averaged in Origin. 
 
Figure 20. Corresponding hyperspectral data of Vero 76 cells exposed to a) 0, b) 1.0, and 
c) 3.0 mg L-1 of AgNPs for 2 hr. 
 
The control cell (0 mg L-1) was observed to have a peak at 559 nm (Figure 20a). This 





exposures of AgNPs, it was observed that the spectral fingerprint widens ever so slightly 
(Table 4). This suggests that the AgNPs are interacting with the cell at the 1 mg L-1 
AgNP exposure. 
Table 4. Spectra maxima and full width half maximum of cell and AgNPs at each 
exposure concentration for 2 hr. 
AgNPs Exposure 




0 559 219 
1 581 221 
3 555 190 
 
At 3 mg L-1 AgNP exposure, the peak obtained by averaging all AgNPs together, was 
narrower than the FWHM of the 0 mg L-1 control cell, but broader than any of the 




  Figure 21. CytoViva optical images overlaid with fluorescence images of exposed Vero 
76 cells after exposure to a) 0, b) 0.1, c) 1.0, and d) 3.0 mg L-1 of starch-capped AgNPs 
for 4 hr. All cells were stained with 150 nM of Mito-tracker red dye prior to AgNP 





Figure 21 displays the CytoViva optical images of cells superimposed on the 
corresponding fluorescence images after 4 hr exposure to various concentrations of 
AgNPs. Figure 21a displays the image of a healthy cell and even mitochondrial 
distribution. At an exposure concentration of 0.1 mg L-1 of AgNPs for 4 hr, the cell 
membrane appears rough, almost oval in shape, and cell debris was observed on the slide. 
As the exposure concentration was increased, the amount of cell debris on the slide 
increased and finding a fixed cell for imaging became more difficult. Figure 22 displays 
the corresponding averaged hyperspectral data for the various concentrations of AgNPs at 
the exposure time of 4 hr. Data from all AgNPs seen on the cell were collected and then 
averaged in Origin. 
Figure 22a and 22b,  suggest interaction of AgNPs with the cells at exposure 
concentrations of 1.0 and 3.0 mg L-1. This can be concluded based on the shifts in peak 
position and peaks FWHM (Table 5). The control cell peak corresponding to the 4 hr 
exposure to AgNPs was similar to the one after 2 hr exposure. 
Figure 22. Corresponding hyperspectral data of Vero 76 cells exposed to a) 1.0, and b) 





Table 5. Spectra maxima and full width half maximum of cell and AgNPs at each 
exposure concentration for 4 hr. 
AgNPs Exposure 




0 559 219 
1 554 188 
3 587 201 
 
At the 1 mg L-1 AgNP exposure concentration, the FWHM was narrower than that of the 0 
mg L-1 control cell, but wider than the FWHM of the AgNPs alone. This suggests there is 
interaction between the AgNP and the cell. The same observation was made at the 3           





Figure 23 displays the CytoVivia optical images of cells superimposed on the 
corresponding fluoresence images after 12 hr exposure at various concentrations of AgNPs. 
With increased exposure time, the toxicological effects of the AgNPs can clearly be 
observed. As the concentration was increased for this exposure time, the cell morphology 
was negatively impacted indicating cytotoxicity. At the highest exposure concentration of 
3 mg L-1 of AgNPs, the cells were deformed. Furthermore, fluoresence images could not 
be collected to the the large amount of cell debris present on the slide at this concentration. 
Figure 23. CytoViva optical images overlaid with fluorescence images of exposed Vero 
76 cells to a) 0, b) 0.1, c) 1.0, and d) 3.0 mg L-1 for 12 hr. All cells were stained with 100 





Figure 24 displays the corresponding hyperspectral data for the mentioned 12 hr exposures 
conditions.  
 
Figure 24. Corresponding hyperspectral data of Vero 76 cells exposed to at a) 0.1, b) 3.0, 
and c) 1.0 mg L-1 of AgNPs for 12 hr. 
These hyperspectral data of all exposure concentrations of AgNPs suggest interaction of 
AgNPs with the cell. The strongest cellular interaction with AgNPs seemed to occur at the 






Table 6. Spectra maxima and full width half maximum of cell and AgNPs at each 
exposure concentration for 12 hr. 
AgNPs Exposure 




0 559 219 
0.1 585 210 
1 582 252 
3 579 152 
 
From both the CytoViva images and hyperpectral data, it suggests that there is interaction 
between the AgNPs and the cell.  
A two sample t-test was performed to determine if there was a significant difference 
between the FWHM at different exposure times and concentrations. When comparing the 
2 hr and 4 hr exposure times, the p-value was determined to be 0.14 indicating no 
signicant difference. At the 2 hr and 12 hr exposure times, the p-value was determined to 
be 0.28, again indicating no significant difference. The p-value for the 4 hr and 12 hr 
exposure times was determined to be 0.47 showing no sigificant difference. 
Hyperspectral data and FWHM values for AgNP exposures at 1 and 3 mg L-1 were able 
to be collected for 2, 4, and 12 hr exposure times. A two sample t-test was performed to 
determine if there was any statistical significane between these FWHM values. The p-
value was found to be 0.09, indicating no siginicant difference between these FWHM 
values at these exposure concentrations. Since the data is not signicantly different, a trend 
cannot be determined from the FWHM data. However, the CytoViva otpical image data 




Figure 25. CytoViva optical images overlaid with fluorescence images of exposed Vero 76 
cells to a) 0, b) 0.1, c) 1.0, and d) 3.0 mg L-1 for 24 hr. All cells were stained with 100 nM 
Mito-tracker red dye prior to AgNP exposure. All scale bars are 25 µm. 
Figure 25 displays the CytoViva optical images of cells superimposed on the 
corresponding fluorescence images after the 24 hr exposure to various concentrations of 
AgNPs. A similar trend was observed as in the 2, 4, and 12 hr exposures. The interaction 
of the AgNPs increased as the time and concentration were increased. This was 






Figure 26. Corresponding hyperspectral data of Vero 76 cells exposed to a) 1.0, and b) 
3.0 mg L-1 of AgNPs for 24 hr. 
The hyperspectral data from both 1.0 and 3.0 mg L-1 were observed to have to 2 peaks. 
This may be occurring because of the AgNPs interaction with the cells are causing cell 
death and contents leaking out. FWHM could not be calculated for these exposures.  
3.4. Analysis of Exposed Vero 76 Cells by ICP-OES 
During the mitochondrial isolation process, ten samples for each exposure (90 samples 
total) were collected and analyzed by ICP-OES. Eleven samples fell above the limit of 
detection (LOD), but only three samples were above the limit of quantification (LOQ) 










Table 7. Silver concentration in exposed AgNP samples taken during the mitochondrial 









Incubated DMEM w/AgNPs  0.1 53* 53 
Cytosol fraction 1 17* 2 
Other cellular components 1 95* 10 
PBS wash 1 1 72* 7 
Incubated DMEM w/AgNPs 1 862 86 
Mitochondria pellet 1.5 12* 1 
Cytosol fraction 1.5 92* 6 
Other cellular components  1.5 68* 5 
DMEM supernatant 2  1.5 51* 3 
PBS wash 1 1.5 151 10 
Incubated DMEM w/AgNPs 1.5 1161 77 
*Samples fell below the LOQ of 5 µg L-1. 
The samples above the LOQ show that most of the AgNPs remained in incubated DMEM 
w/AgNPs. At the 1 mg L-1 exposure, 86% of the AgNPs were found in the incubated 
DMEM. At 1.5 mg L-1, 77% of the AgNPs remained in the incubated DMEM, while 10% 
of the AgNPs remained in the PBS wash 1. Samples above the LOD show that AgNPs 
are entering the cell, but the amount could not be report with accuracy. A repeated 
measures ANOVA was run to determine if there were any significant differences between 
the four AgNP exposure concentrations (0, 0.1, 1.0, and 1.5 mg L-1) and at the various 
stages of the experiment ranging from sample 1 to sample 10. Since not all samples were 
above the LOD, not every sample is represented for each experiment. A level of 
significance of α = 0.05 was used to assess statistical significance and SAS version 9.4 
was used for all analyses. Statistical analysis was run by the Statistics Consulting Center 




Table 8. Descriptive statistics for ICP-OES analysis by concentration and sample. Sample 










PBS wash 1 6 63.83 27.87 29.33 108.12 
Media supernatant 3 63.88 28.51 36.44 93.36 
Other cellular 
components 
9 129.2 28.07 65.95 164.79 
Cytosol fraction 3 70.03 7.59 63.61 78.4 
Mitochondria pellet 3 67.88 17.79 49.9 85.48 
0.1 Incubated DMEM 
w/AgNPs 









PBS wash 1 9 173.88 38.85 109.16 244.59 
Other cellular 
components 
9 202.33 61.39 139.54 279.78 




9 1483.8 92.07 1353.51 1600.99 
PBS wash 1 9 269.76 47.08 211.56 343.95 
Media Supernatant 9 148.72 32.25 108.14 207.41 
Other cellular 
components 
9 169.62 25.63 116.57 199.09 
Cytosol fraction 9 198.11 42.23 129.27 250.48 
Mitochondria pellet 9 102.11 22.79 70.57 131.59 
 
From the descriptive statistics in Table 8, 45 comparisons of interest were made. Of those 
45 comparisons, 31 compared the ICP-OES mean values between samples within the 
same concentration, and 14 compared the ICP-OES mean values of the samples within 
the same concentration. A stepdown Bonferroni multiple comparison procedure was 
utilized in order to control the potential for type I error rate, this is when significance is 
claimed, but there are none. A confidence level of 95 % at most was utilized, this was 
calculated via Bonferroni multiple comparison procedure. These results are contained in 
Supporting Information (Table S2). 
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Samples within the AgNP exposure concentration 0 mg L-1, there was not adequate 
evidence to suggest any significant differences among all comparisons (all p-values were 
0.99). At AgNP exposure concentration 0.1 mg L-1, there was only one sample that was 
above the LOD, therefore no comparisons between samples at this concentration could be 
made.  
Samples within AgNP exposure concentration 1.0 mg L-1, there is strong evidence 
suggesting a significant mean difference between sample 1 and sample 2 (p-vale < 
0.0001). A significant mean difference between sample 1 and sample 7, having a p-value 
of < 0.001. There was also strong evidence suggesting there is a mean difference between 
sample 1 and sample 8 (p-value < 0.0001). No other significant differences were 
detected. 
Samples within the AgNP exposure concentration 1.5 mg L-1, there was strong evidence 
suggesting a significant mean difference between: sample 1 and sample 2, sample 1 and 
sample 6, sample 1 and sample 7, sample 1 and sample 8, sample 1 and sample 10. All 
comparisons with a significant mean difference had a p-value of < 0.0001. No other 
significant differences were detected within the samples at this concentration. 
The only comparison that could be made between different AgNP exposure 
concentrations were with sample 1. There was strong evidence suggesting a significant 
mean difference between sample 1 for the following concentrations: 0.1 and 1.0 mg L-1, 
0.1 and 1.5 mg L-1, 1 and 1.5 mg L
-1. Between AgNP exposure concentrations 0.1 and 1.0 
mg L-1, the p-value was determined to be < 0.0001. The p-value between AgNP exposure 
concentrations 0.1 and 1.5 mg L-1 was also < 0.0001. Lastly, between AgNP exposure 
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concentrations 1.0 and 1.5 mg L-1, the p-value was determined to equal 0.0005. No other 
significant differences were detected. 
All significant differences detected involved sample 1, however, data for sample 1 at 0 
mg L-1 was not reliable, therefore no conclusions could be drawn about it relative to other 
samples at 0 mg L-1 or compared to other concentrations at sample 1. No conclusions 
could be drawn at the AgNP exposure concentration 0.1 mg L-1 due to only sample 1 data 





From CytoViva images, it was observed as concentration of AgNPs and time increased, 
more cell death occurred, which correlates to the proposed hypothesis. This could be 
clearly seen by the morphological changes to cell shape as the time and concentration of 
AgNPs was increased. From the hyperspectral data collected of exposed cells at various 
concentrations, it suggests that there is interaction between the cell and AgNPs. In the 
future, implementing the 3-D camera on CytoViva would help determine if the AgNPs 
are interacting with the cell wall and/or have entered the cytosol. This would give insight 
into the possible mechanism of how AgNPs are entering the cell and causing cell death. 
From ICP-OES data, it was determined that there were significant mean differences 
between some samples within the same concentration and between sample 1 at different 
exposure concentrations. It can be concluded that AgNPs did enter the mitochondria of 
the cells, however, the amount could not be quantified. To produce more accurate results, 
concentrations used for exposures need to be increased and the exposure time should be 
increased as well to increase the chances of AgNPs entering the mitochondria. The 
sample preparation of biological samples for ICP-OES should also be adjusted to a 
smaller dilution factor. 
The AgNP synthesis could be optimized for a higher yield. Perhaps less starch could be 
used, eliminating the purification via centrifugated step. Also, doing a large batch-wise 
process, larger surface area TFF filter, and a peristaltic pump would increase yield and 
efficiency. It was observed that the colloid became gel-like when the excess starch was 
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not removed before filtration of the original colloid. A future application of starched-
capped AgNP synthesis, could be to use this gel-like colloid in the medical field, perhaps 
in a burn gel. 
The main aim of this study was to determine if AgNPs were entering the mitochondria of 
Vero 76 cells, quantify the total silver content, and look at AgNP distribution within the 
cell. It was determined AgNPs are entering the cell, but the ICP-OES signal fell below 
the LOQ. To quantify the total silver content within these biological matrices, the 
exposure concentrations of AgNPs should be increased and the dilution factor used in 
sample preparation decreased. 
Future Raman spectroscopy experiments should be performed to investigate the 
mechanism of AgNP formation and of AgNP-cellular interaction. CytoViva 3-D imaging 
should be employed to give insight if the AgNP is interacting with the cellular wall 
and/or components inside the cell. Lastly, MTT and ROS assays should also be 
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6. Supporting Information 
Table S1. List of sample names for each step of the mitochondrial isolation assay. 
Sample Number Sample Name 
1 Incubated DMEM w/AgNPs 
2 PBS wash 1 
3 PBS wash 2 
4 PBS wash 3 
5 Media supernatant 1 
6 Media supernatant 2 
7 Other Cellular components 
8 Cytosol fraction 
9 Mitochondrial pellet wash 
10 Mitochondria pellet 
 
Table S2. Statistical summary of the stepdown Bonferroni procedure for ICP-OES 
measurements utilizing a 95% confidence level. 
Comparison (mg L-1) Estimate Standard Error p - value 
Concentration 0: Sample 2 - 6 -0.05 99.38 0.99 
Concentration 0: Sample 2 - 7 -65.37 74.07 0.99 
Concentration 0: Sample 2 - 8 -6.2 99.38 0.99 
Concentration 0: Sample 2 - 10 -4.05 99.38 0.99 
Concentration 0: Sample 6 - 7 -65.32 93.7 0.99 
Concentration 0: Sample 6 - 8 -6.15 114.75 0.99 
Concentration 0: Sample 6 - 10 -4 114.75 0.99 
Concentration 0: Sample 7 - 8 59.17 93.7 0.99 
Concentration 0: Sample 7 - 10 61.32 93.7 0.99 
Concentration 0: Sample 8 - 10 2.15 114.75 0.99     
Concentration 1: Sample 1 - 2 950.58 66.25 < 0.0001 
Concentration 1: Sample 1 - 7 922.12 66.25 < 0.0001 
Concentration 1: Sample 1 - 8 1014.08 74.07 < 0.0001 
Concentration 1: Sample 2 - 7 -28.45 66.25 0.99 
Concentration 1: Sample 2 - 8 63.51 74.07 0.99 
Concentration 1: Sample 7 - 8 91.96 74.07 0.99     
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Concentration 1.5: Sample 1 - 2 1214.04 66.25 < 0.0001 
Concentration 1.5: Sample 1 - 6 1335.08 66.25 < 0.0001 
Concentration 1.5: Sample 1 - 7 1314.18 66.25 < 0.0001 
Concentration 1.5: Sample 1 - 8 1285.7 66.25 < 0.0001 
Concentration 1.5: Sample 1 - 10 1381.7 66.25 < 0.0001 
Concentration 1.5: Sample 2 - 6 121.04 66.25 0.99 
Concentration 1.5: Sample 2 - 7 100.14 66.25 0.99 
Concentration 1.5: Sample 2 - 8 71.66 66.25 0.99 
Concentration 1.5: Sample 2 - 10 167.65 66.25 0.62 
Concentration 1.5: Sample 6 - 7 -20.9 66.25 0.99 
Concentration 1.5: Sample 6 - 8 -49.38 66.25 0.99 
Concentration 1.5: Sample 6 - 10 46.61 66.25 0.99 
Concentration 1.5: Sample 7 - 10 -28.48 66.25 0.99 
Concentration 1.5: Sample 7 - 8 67.52 66.25 0.99 
Concentration 1.5: Sample 8 - 10 96 66.25 0.99     
Sample 1: 0.1 - 1 -972.8 66.25 < 0.0001 
Sample 1: 0.1 - 1.5 -1332.15 66.25 < 0.0001 
Sample 1: 1 - 1.5 -359.35 66.25 0.0005 
Sample 2: 0 - 1 -110 93.7 0.99 
Sample 2: 0 - 1.5 -205.88 93.7 0.99 
Sample 2: 1 - 1.5 -95.89 66.25 0.99 
Sample 6: 0 - 1.5 -19.52 66.25 0.99 
Sample 7: 0 - 1 -132.3 93.7 0.99 
Sample 7: 0 - 1.5 -99.59 93.7 0.99 
Sample 7: 1 - 1.5 32.71 66.25 0.9 
Sample 8: 0 - 1 -40.34 99.38 0.99 
Sample 8: 0 - 1.5 -128.07 93.7 0.99 
Sample 8: 1 - 1.5 -87.74 74.07 0.99 
Sample 10: 0 - 1.5 -34.23 93.7 0.99 
 
